Substance / Medication

Riboflavin sodium phosphate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Ariboflavinosis

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:

Micronutrient-Fortified Milk and Academic Performance among Chinese Middle School Students: A Cluster-Randomized Controlled Trial.

Wang Xiaoqin, Hui Zhaozhao, Dai Xiaoling et al. · Nutrients · 2017

PMID: 28257107RCTFull text (PMC)

The effects of regular consumption of a multiple micronutrient fortified milk beverage on the micronutrient status of school children and on their mental and physical performance.

Kuriyan Rebecca, Thankachan Prashanth, Selvam Sumithra et al. · Clin Nutr · 2016

PMID: 25746819RCT

Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM).

Powers Hilary J, Hill Marilyn H, Mushtaq Sohail et al. · Am J Clin Nutr · 2011

PMID: 21525198RCT

Study Protocol: randomised controlled trial to investigate the functional significance of marginal riboflavin status in young women in the UK (RIBOFEM).

Hill Marilyn H E, Mushtaq Sohail, Williams Elizabeth A et al. · BMC Public Health · 2009

PMID: 19323801RCTFull text (PMC)

Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren.

Vinodkumar Malavika, Rajagopalan Srinivasa · Food Nutr Bull · 2009

PMID: 19927606RCT

Riboflavin status in acute ischaemic stroke.

Gariballa S, Ullegaddi R · Eur J Clin Nutr · 2007

PMID: 17299470RCT

Supplementation with iron and riboflavin enhances dark adaptation response to vitamin A-fortified rice in iron-deficient, pregnant, nightblind Nepali women.

Graham Joanne M, Haskell Marjorie J, Pandey Pooja et al. · Am J Clin Nutr · 2007

PMID: 17490976RCT

Characterization of the binding interaction between bovine hemoglobin and riboflavin sodium phosphate: multi-spectroscopic analysis and molecular docking studies.

Rahimi Ratky Marzieh, Dezhampanah Hamid · J Biomol Struct Dyn · 2025

PMID: 40091678Other

Clinical investigation in effect of riboflavin sodium phosphate on prevention and treatment for patients with radiotherapy related esophagitis.

Shen Kang, Huang Xin-En · Asian Pac J Cancer Prev · 2015

PMID: 25743825Other

[Optimization of riboflavin sodium phosphate loading to calcium alginate floating microspheres by response surface methodology].

Zhang An-yang, Fan Tian-yuan · Beijing Da Xue Xue Bao Yi Xue Ban · 2009

PMID: 20019781Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Riboflavin sodium phosphate (substance)
SNOMED CT: 442346000
UMLS CUI: C0037548

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.